Hartiala, Jaana A.
Wilson Tang, W. H.
Wang, Zeneng
Crow, Amanda L.
Stewart, Alexandre F. R.
Roberts, Robert
McPherson, Ruth
Erdmann, Jeanette
Willenborg, Christina
Hazen, Stanley L.
Allayee, Hooman
Article History
Received: 12 July 2015
Accepted: 29 December 2015
First Online: 29 January 2016
Competing interests
: S.L.H. is named as co-inventor on pending and issued patents held by the Cleveland Clinic relating to cardiovascular diagnostics and therapeutics. S.L.H. reports he has been paid as a consultant or speaker for the following companies: Cleveland Heart Lab, Inc., Esperion and Procter & Gamble. S.L.H. reports he has received research funds from Abbott, Astra Zeneca, Cleveland Heart Lab, Esperion, Procter & Gamble and Takeda. S.L.H. has the right to receive royalty payments for inventions or discoveries related to cardiovascular diagnostics and therapeutics from Cleveland Heart Lab, Inc., Frantz Biomarkers, LLC, Procter & Gamble and Siemens. The remaining authors declare no competing financial interests.